Company Filing History:
Years Active: 2015-2018
Title: The Innovative Contributions of Shaoxin Feng
Introduction
Shaoxin Feng is a notable inventor based in Tustin, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid-like compounds. With a total of 3 patents to his name, his work has the potential to impact various medical treatments.
Latest Patents
Feng's latest patents include innovative formulations and methods related to steroid-like compounds. One of his notable inventions is titled "Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof." This patent describes multiple solid forms of a defined steroid-like compound, including crystalline and amorphous forms, along with methods for their preparation and use. These compositions are designed for the delivery of active agents to subjects in need, particularly for treating conditions such as glaucoma and ocular hypertension.
Another significant patent is "Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof." This invention introduces new crystalline forms of bimatoprost acid, which are useful for solid ocular implant formulations and dosage forms aimed at treating ocular hypertension.
Career Highlights
Shaoxin Feng is currently employed at Allergan, Inc., a leading company in the pharmaceutical industry. His work at Allergan has allowed him to focus on innovative solutions for ocular health, contributing to advancements in treatment options for patients.
Collaborations
Feng has collaborated with notable colleagues, including Scott W. Smith and Ke Wu. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
Shaoxin Feng's contributions to the field of pharmaceuticals, particularly through his patents related to steroid-like compounds, demonstrate his commitment to innovation and improving medical treatments. His work continues to pave the way for advancements in ocular health and beyond.